The CD18−/− mouse model resembles therefore a severe form of the LAD-I syndrome in humans and has been explored in the context of various pathologies like psoriasis [180], wound healing [181], diabetes [182], carditis [183,184], osteoporosis [185], and infections [186]. Here, ITGB2 is linked to psoriasis.